Premium
Bafilomycin A1 inhibits Helicobacter pylori ‐induced vacuolization of HeLa cells
Author(s) -
Papini E.,
Bugnoli M.,
Bernard M.,
Figura N.,
Rappuoli R.,
Montecucco C.
Publication year - 1993
Publication title -
molecular microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 247
eISSN - 1365-2958
pISSN - 0950-382X
DOI - 10.1111/j.1365-2958.1993.tb01123.x
Subject(s) - bafilomycin , vacuolization , vacuole , hela , biology , intracellular , v atpase , intracellular ph , atpase , biochemistry , microbiology and biotechnology , enzyme , cytoplasm , in vitro , apoptosis , autophagy , endocrinology
Summary Bafilomycin A1, a specific inhibitor of the vacuolar‐type H + ‐ATPase, responsible for acidification of intra‐cellular compartments, prevents the vacuolization of Hela cells induced by H. pylori , with an inhibitory concentration giving 50% of maximal (ID 50 ) of 4 nM. Bafilomycin A1 is also very efficient in restoring vacuolated cells to a normal appearance. The vacuolating activity of Helicobacter pylori is not inhibited by a series of specific inhibitors of vacuolar H + ‐ATPases. These findings indicate that a transmembrane pH gradient is needed for the formation and growth of vacuoles caused by the bacterium and that this pH gradient is due to the activity of a vacuolar ATPase proton pump of HeLa cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom